Health-related quality of life and patient-reported outcomes of ofatumumab plus fludarabine and cyclophosphamide versus fludarabine and cyclophosphamide in the COMPLEMENT 2 trial of patients with relapsed CLL.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Yaroslav Kulyaba Grygoriy Rekhtman K Govind Babu Iryna Kryachok Astrid McKeown Wojciech Homenda Ira V Gupta Kazimierz Kuliczkowski Sebastian Grosicki Janusz Kłoczko Krzysztof Warzocha Tadeusz Robak Jerzy Z. Blonski |
| Publication date | November 10, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |